Can telehealth bring HIV prevention to rural drug users?

NCT ID NCT06845774

ENROLLING_BY_INVITATION Prevention Sponsor: Hilary L Surratt, PhD Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether offering HIV prevention medication (PrEP) through telehealth visits at local health departments helps more people who inject drugs start and stay on PrEP compared to standard education and referrals. Eighty participants in rural Appalachia will be randomly assigned to either the telehealth program or standard care. The goal is to see if removing travel and provider barriers can increase PrEP use in this underserved group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TelePrEP (telehealth-based PrEP care)
What this could lead to: If successful, this approach could make HIV prevention more accessible for people who inject drugs in rural areas, reducing new infections.
What could go wrong: This is a small pilot study with only 80 participants, so results may not apply broadly. Telehealth may not overcome all barriers to PrEP adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION

Contacts and locations

Show contact details

Locations

University of Kentucky

Lexington, Kentucky, 40536, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.